Andrew Alexis, MD, MPH, a Professor of Clinical Dermatology and Vice-Chair for Diversity and Inclusion at Weill Cornell Medicine in New York, NY, provides an update on the latest crop of hydroquinone alternatives, including thiamidol and cysteamine. He also highlights recent advances in treating vitiligo in this must-watch video.